Market Research Logo

Global Antipsychotic Drugs Market 2017-2021

Global Antipsychotic Drugs Market 2017-2021

About Antipsychotic Drugs

Antipsychotic drugs are also called as major tranquilizers or neuroleptics. These drugs are primarily used for the treatment of psychiatric disorders such as schizophrenia, hallucinations, delusions, bipolar disorder, and others. The antipsychotic drugs market is expected to grow due to the rising number of schizophrenic patients.

Technavio’s analysts forecast the global antipsychotic drugs market to grow at a CAGR of 1.84% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global antipsychotic drugs market for 2017-2021. To calculate the market size, the report considers sales from both branded and generic drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Antipsychotic Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AstraZeneca
  • Eli Lilly
  • GlaxoSmithKline
  • Johnson & Johnson
Other prominent vendors
  • Actavis Generics (a subsidiary of Teva Pharmaceutical Industries)
  • Alkermes
  • Bristol-Myers Squibb
Market driver
  • Increasing expenditure on prescription drugs
  • For a full, detailed list, view our report
Market challenge
  • Lack of standard diagnostic methods
  • For a full, detailed list, view our report
Market trend
  • Rising public interest toward mental health
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Antipsychotic Drugs Market 2017-2021

Technavio recognizes the following companies as the key players in the global antipsychotic drugs market: AstraZeneca, Eli Lilly, GlaxoSmithKline, and Johnson & Johnson.

Other Prominent Vendors in the market are: Actavis Generics (a subsidiary of Teva Pharmaceutical Industries), Alkermes, and Bristol-Myers Squibb.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is rising public interest toward mental health. The rising public interest for the management of depression by government bodies such as the CDC is an important trend being witnessed in the market. The CDC plays an important role in the integration of mental well-being with public health.”

According to the report, one driver in the market is increasing expenditure on prescription drugs. The global antipsychotic drugs market has witnessed a large shift in the clinical and economic role of prescription drugs, owing to policy changes in the healthcare sector, availability of insurance coverage, the introduction of behavioral healthcare techniques, and marketing strategies adopted by pharmaceutical companies to promote their product.

Further, the report states that one challenge in the market is lack of standard diagnostic methods. Accurate diagnosis of a disease helps in prescribing appropriate treatment regimen and impact around 60% of physicians' clinical decision. Most of the mental disorders can be effectively managed if they are diagnosed at an early stage. However, the lack of suitable diagnostic procedures will lead to underdiagnosed population and treatment will become more complex if a disorder is diagnosed at an advanced stage.



Companies Mentioned

AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Actavis Generics (a subsidiary of Teva Pharmaceutical Industries), Alkermes, and Bristol-Myers Squibb.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
      • Table Reduction in prescription revenue over the years for antipsychotic drugs due to entry of generics
  • Disease overview
    • Psychosis
    • Symptoms of psychiatric disorder
      • Table Signs and symptoms of psychiatric disorder
    • Causes of psychiatric disorder
      • Table Causes of psychiatric disorder
    • Treatment of psychiatric disorder
    • Medical use of antipsychotic drugs
      • Table List of medical conditions in which antipsychotic drugs used for the treatment
  • Key clinical trials
    • Table Stages of key clinical trials in global antipsychotic drugs market 2016
    • Table Snapshot of pipeline trends in global antipsychotic drugs market
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global antipsychotic drugs market 2016-2021 ($ millions)
      • Table Global antipsychotic drugs market: Opportunity analysis
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by disease type
    • Market overview based on disease type
      • Table Segmentation of global antipsychotic drugs market by disease type
      • Table Market share of global antipsychotic drugs market by disease type 2016
    • Schizophrenia
    • Bipolar disorder
    • Unipolar depression
    • Dementia
    • Others
  • Market segmentation based on MoA
    • Market overview based on MoA
      • Table Global antipsychotic drugs market segmentation based on MoA 2016
    • First-generation antipsychotic drugs market
      • Table Global first-generation antipsychotic drugs market 2016-2021 ($ millions)
    • Second-generation antipsychotic drugs market
      • Table Global second-generation antipsychotic drugs market 2016-2021 ($ millions)
    • Third generation antipsychotic drugs market
      • Table Global third-generation antipsychotic drugs market 2016-2021 ($ millions)
  • Geographical segmentation
    • Market overview based on geography
      • Table Segmentation of global antipsychotic drugs market by geography 2016 and 2021
      • Table Global antipsychotic drugs market revenue by geography 2016-2021 ($ millions)
      • Table Global antipsychotic drugs market share by geography 2016-2021
    • Antipsychotic drugs market in Americas
      • Table Market scenario in Americas
      • Table Antipsychotic drugs market in Americas 2016-2021 ($ millions)
    • Antipsychotic drugs market in EMEA
      • Table Market scenario in EMEA
      • Table Antipsychotic drugs market in EMEA 2016-2021 ($ millions)
    • Antipsychotic drugs market in APAC
      • Table Market scenario in APAC
      • Table Antipsychotic drugs market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Rising public interest toward mental health
    • Increase in use of LAI antipsychotic drugs
    • Antipsychotics with novel MoA
  • Vendor landscape
    • Competitive landscape
      • Table Competitive structure analysis of global antipsychotic drugs market 2016
  • Key vendor analysis
    • AstraZeneca
      • Table AstraZeneca: Strength assessment
      • Table AstraZeneca: Strategy assessment
      • Table AstraZeneca: Opportunity assessment
      • Table AstraZeneca: Year-over-year (YoY) and growth rate of SEROQUEL XR and SEROQUEL IR 2014-2015 ($ millions)
    • Eli Lilly
      • Table Eli Lilly: Key highlights
      • Table Eli Lilly: Strength assessment
      • Table Eli Lilly: Strategy assessment
      • Table Eli Lilly: Opportunity assessment
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Strength assessment
      • Table GlaxoSmithKline: Strategy assessment
      • Table GlaxoSmithKline: Opportunity assessment
    • Johnson & Johnson
      • Table Johnson & Johnson: Key highlights
      • Table Johnson & Johnson: Strength assessment
      • Table Johnson & Johnson: Strategy assessment
      • Table Johnson & Johnson: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report